ROYAL BANK OF CANADA - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 41 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,000
-25.0%
5,094
-5.1%
0.00%
Q2 2023$4,000
+100.0%
5,368
+11.4%
0.00%
Q1 2023$2,000
-33.3%
4,8200.0%0.00%
Q4 2022$3,0000.0%4,820
-5.8%
0.00%
Q3 2022$3,000
-57.1%
5,119
+6.2%
0.00%
Q2 2022$7,000
-61.1%
4,8200.0%0.00%
Q1 2022$18,000
+12.5%
4,820
+141.0%
0.00%
Q4 2021$16,0002,0000.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
First PREMIER Bank 807,535$4760.14%
Warberg Asset Management LLC 370,370$218,5180.03%
METEORA CAPITAL, LLC 134,524$79,3560.02%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 149,774$88,3520.02%
SILVER OAK SECURITIES, Inc 51,941$310.01%
Veritable, L.P. 506,513$298,7920.01%
Shaolin Capital Management LLC 236,621$1400.00%
Elgethun Capital Management 14,796$9,1710.00%
LGL PARTNERS, LLC 23,000$13,5680.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,000$49,5520.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders